Physician

Abeer S Fayyad, MD

According to 2025 Medicare claims, Abeer Fayyad, MD (NPI: 1093704785) practices internal medicine in the Flint, MI market, with the plurality of this provider's patient population coming from Genesee, MI. This provider's primary affiliated billing organization is INTERNAL MEDICINE HEALTH CENTER PC (NPI: 1265755243; TIN: 352375813) and primary practice location at 48507-2971. Fayyad is affiliated with the CCA ACO LLC (ACO ID: A2198), participating under the MSSP model.

Fayyad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 216 traditional Medicare patients, billed 2,897 HCPCS/CPT codes, and received $90,543 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 11,520 prescription claims across 561 beneficiaries totaling $1,189,554 in drug costs, led by Eliquis (Apixaban). DME data shows 143 claims. Open Payments data shows 26 records totaling $441. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $129,397 to $90,543. In contrast, Part D prescription costs have risen steadily, from $712,875 to $1,189,554. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $12,457 and ending at $13,155.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	218	3,132	$129,397
2016	239	3,277	$131,840
2017	242	3,774	$181,590
2018	214	2,966	$116,190
2019	207	2,683	$108,789
2020	188	2,378	$98,451
2021	171	2,324	$106,602
2022	173	1,999	$97,860
2023	211	1,824	$88,462
2024	216	2,897	$90,543

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	352	10,149	$712,875
2016	367	9,410	$691,127
2017	361	8,848	$663,732
2018	314	7,262	$622,034
2019	297	6,808	$626,583
2020	288	7,184	$743,992
2021	358	7,996	$891,885
2022	375	8,406	$893,040
2023	465	9,564	$1,102,511
2024	561	11,520	$1,189,554

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	107	497	$12,079
2016	104	478	$10,419
2017	102	473	$8,782
2018	84	348	$6,248
2019	69	432	$8,410
2020	57	366	$6,704
2021	18	279	$8,985
2022	25	196	$3,875
2023	N/R	166	$9,304
2024	N/R	143	$11,809

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	55	55	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	194	579	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	63	103	$56
96372	Injection of drug or substance under skin or into muscle	60	150	$9
81002	Urinalysis, manual test	80	100	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	106	7,477	$138,690
Jardiance	Empagliflozin	120	7,320	$136,725
Mounjaro	Tirzepatide	55	2,940	$102,742
Trulicity	Dulaglutide	43	2,912	$93,256
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	94	3,840	$79,292

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$7,385
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	27	$1,530
A4407	Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each	N	N/R	11	$937
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	25	$729
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	13	$413

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$441	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abeer S. Fayyad, MD?

Tedicare shows public-source Medicare data for Abeer S. Fayyad, MD (NPI 1093704785), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abeer S. Fayyad, MD have ACO affiliation data?

Abeer S. Fayyad, MD is shown with ACO affiliation data for CCA ACO LLC (MSSP, ACO ID A2198).

What billing organization is linked to Abeer S. Fayyad, MD?

Abeer S. Fayyad, MD is linked to INTERNAL MEDICINE HEALTH CENTER PC (billing NPI 1265755243) in the available physician profile data.

Does Abeer S. Fayyad, MD have Open Payments data?

Abeer S. Fayyad, MD has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.